
Prevnar 13 | FDA - U.S. Food and Drug Administration
Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 weeks through...
Pneumococcal Vaccine Recommendations - CDC
Oct 26, 2024 · CDC also recommends pneumococcal vaccination for children and adults at increased risk for pneumococcal disease. Follow the recommended immunization schedule to ensure that your patients get the pneumococcal vaccines that they need.
Recommended Vaccines for Adults | Pneumococcal | CDC
Oct 26, 2024 · Adults who received an earlier PCV (PCV7 or PCV13) should talk with a vaccine provider. The provider can explain available options to complete the pneumococcal vaccine series. Adults 65 years or older have the option to get PCV20 or PCV21, or to not get additional pneumococcal vaccines.
PREVNAR® 13 Dosage and Administration - Pfizer Medical …
Prevnar 13 is to be administered as a four-dose series at 2, 4, 6, and 12–15 months of age. Dose 1 may be given as early as 6 weeks of age. The recommended dosing interval is 4 to 8 weeks. The fourth dose should be administered at approximately 12–15 months of age, and at least 2 months after the third dose.
In adults 18 years of age and older, Prevnar 13 is indicated for: active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae
Prevnar 20: Uses, Dosage, Side Effects - Drugs.com
Nov 29, 2024 · Prevnar 20 is a vaccine used to prevent pneumococcal disease, a serious bacterial infection of the lungs (pneumonia), blood (bacteremia), brain (meningitis), ear infections, and sinus infections caused by pneumococcal bacteria. The Prevnar 20 vaccine protects against 20 types of Streptococcus pneumonia bacteria.
PREVNAR 13 | Pfizer
This product information is intended only for residents of the United States.
PREVNAR® 13 Indications and Usage - Pfizer Medical Information
In adults 18 years of age and older, Prevnar 13 is indicated for: active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.
Pneumococcal conjugate vaccine (PCV13) - What you need to know
Jan 30, 2025 · There are three pneumococcal conjugate vaccines (PCV13, PCV15, and PCV20). The different vaccines are recommended for different people based on age and medical status. Your health care provider can help you determine which type of pneumococcal conjugate vaccine, and how many doses, you should receive.
Pneumococcal Vaccine (Prevnar, Prevnar 13): Benefits
The pneumococcal vaccine prevents pneumococcus bacterial infections that cause pneumonia and meningitis. Children and adults can get this vaccine.